Treatment of liver disease in New Jersey and the United States has its roots at University Hospital, New Jersey Medical School. An early pioneer and co-founder of the American Association for the Study of Liver Disease, Carroll M Leevy MD, started the Sammy Davis Jr National Liver Institute at the New Jersey Medical School in Newark during the early 1980's. The center was a beacon of hope for patients suffering from liver disease and liver cancer through out the northeast for over 20 years. To compliment the Sammy Davis Jr. Liver Institute, a liver transplant program was started in 1988. To date, well over a thousand people suffering from liver failure have received a life saving liver transplant in New Jersey. However, for each patient who receives a liver transplant, there are 500-1000 people with cirrhosis in our state.

Comprehensive Medical and Surgical Liver Care of New Jersey is a network of liver specialists dedicated to providing the highest quality care to patients suffering from liver disease in the our state. Physicians in the network are identified by their volume, experience, number of clinical trials, research, and willingness to care for patients afflicted with liver disease in New Jersey. Specialties include hepatology & gastroenterology, infectious disease, advanced surgery, interventional radiology, interventional endoscopy, radiation oncology, and medical oncology.

Increasing liver cancer survival requires a multidicsiplinary approach entailing public education, high risk population surveillance, early diagnosis, and advanced therapeutics. Liver cancer patients cared for by Comprehensive Liver Care of New Jersey physicians acheive a liver cancer survival almost double the national average. Although patients referred for liver cancer care through the network benefit from better survival, there is still much that needs to been done. In the state of New Jersey over 66,000 people are chronically infected with hepatitis B and 135,000 people chronically infected with hepatitis C. Over the next decade 20-30% of these people will develop cirrhosis and will have a high risk for liver cancer and liver failure.

Data derived from New Jersey Medical Medical School Cancer Center Tumor Registry

In addition to providing the highest quality care to patients with chronic liver disease and liver cancer, physicians in this network have a history of dedication to programs that improve advocacy education, prevention, and early diagnosis in order to reduce the risk of cirrhosis, liver failure and liver cancer.